Elsevier

Survey of Ophthalmology

Volume 58, Issue 4, July–August 2013, Pages 348-358
Survey of Ophthalmology

Public Health and the Eye
High-Risk Populations for Vision Loss and Eye Care Underutilization: A Review of the Literature and Ideas on Moving Forward

https://doi.org/10.1016/j.survophthal.2012.07.005Get rights and content

Abstract

Much work has been done to highlight and understand the significant disparities in the use of eye care services, but they continue to exist. We review the existing literature on utilization in high-risk populations to provide a context for understanding what “high-risk” means, to understand the utilization patterns among high-risk populations, and to highlight barriers to appropriate eye care utilization. We also discuss potential approaches to reduce these disparities.

Section snippets

High-Risk Populations for Vision Loss

Defining high-risk populations for vision loss is no simple task. There is a wide range of eye diseases and conditions that lead to vision loss or blindness. So although there is some overlap in defining those at high risk for eye disease and resulting vision loss, each disease has its own specific set of risk factors. The major causes of vision loss in the United States include diabetic retinopathy, cataracts, glaucoma, age-related macular degeneration, and refractive error, as summarized in

High-risk Populations for Underutilization of Eye Care

With an aging population, understanding the issues surrounding access to and utilization of eye care services becomes increasingly important. Services are utilized less often in certain populations, and the definition of high-risk for underutilization varies with different studies in different locations. The American Academy of Ophthalmology offers guidelines for frequency of eye examinations according to age and risk factors.A Eye examinations are recommended for all persons aged 65 and older

Barriers to Care: Perceptions and Expectations

Along with the study of why health disparities exist and how to eliminate them has come the development and integration of several theories and models of human behavior. Two in particular, the Health Belief Model and the Social Learning/Social Cognitive Theory, are quite relevant to understanding the barriers to care. They both highlight the role of perceived outcomes of behavior and the influence of those perceptions of control over the behavior.15, 73, D These models have been applied to a

Moving Forward to Increasing Eye Care Utilization

We conclude that, even though defining groups at high risk for vision loss varies with eye disease or condition, minorities, people of low SES, and the elderly appear to be at greatest risk for vision loss. Despite their increased risk, members of minority groups, those of low SES, and the uninsured do not use or receive adequate eye care. Patients have expectations that, if unmet, may influence utilization, and patients' perceived barriers and attitudes toward eye care differ significantly

Conclusion

Much work has been done to identify high-risk populations in eye care. Utilization of eye care services differs among age groups, sexes, races/ethnicities, and socioeconomic levels. Several groups have even determined perceived barriers to care by directly asking patients themselves. There is still more information needed, however. A next step in reducing disparities in eye care is to seek the input of high-risk individuals on ways to improve their care. Understanding more about why they

Method of Literature Search

We performed a systematic review of the existing literature to answer the following questions:

  • 1.

    What defines “high risk” for vision loss in eye care?

  • 2.

    Who is at “high risk” for not using eye care?

  • 3.

    What are some of the barriers that hinder certain groups from obtaining proper eye care?

An initial Medline search was performed on September 3, 2007, and again on April 18, 2010, surveying literature published in English from 1966 to 2010, using combinations of relevant key words. The initial Medline

Disclosure

The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

References (101)

  • L. Racette et al.

    Primary open-angle glaucoma in blacks: a review

    Surv Ophthalmol

    (2003)
  • B. Rahmani et al.

    The cause-specific prevalence of visual impairment in an urban population: The Baltimore Eye Survey

    Ophthalmology

    (1996)
  • J. Rodriguez et al.

    Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics

    Ophthalmology

    (2002)
  • S.C. Tomany et al.

    Risk factors for incident age-related macular degeneration

    Ophthalmology

    (2004)
  • R. Varma et al.

    Biologic risk factors associated with diabetic retinopathy

    Ophthalmology

    (2007)
  • M.R. Wilson et al.

    Ophthalmologic disorder in minority populations

    Med Clin N Am

    (2005)
  • Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 19

    Ophthalmology

    (2005)
  • The Advanced Glaucoma Intervention Study (AGIS): baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma

    Am J Ophthalmol

    (2002)
  • Causes and prevalence of visual impairment among adults in the United States

    Arch Ophthalmol

    (2004)
  • The prevalence of age-related macular degeneration among adults in the United States

    Arch Ophthalmol

    (2004)
  • The prevalence of cataract and psuedophakia/aphakia among adults in the United States

    Arch Ophthalmol

    (2004)
  • The Prevalence of diabetic retinopathy among adults in the United States

    Arch Ophthalmol

    (2004)
  • The prevalence of open-angle glaucoma among adults in the United States

    Arch Ophthalmol

    (2004)
  • The prevalence of refractive errors among adults in the United States, Western Europe and Australia

    Arch Ophthalmol

    (2004)
  • N.E. Adler et al.

    Socioeconomic disparities in health: Pathways and policies

    Health Affairs

    (2002)
  • N.E. Adler et al.

    Socioeconomic status and health: What we know and what we don’t

    Ann New York Acad Sci

    (1999)
  • R.L. Alexander et al.

    Factors that influence the receipt of eye care

    Am J Health Behav

    (2008)
  • E.M. Andresen et al.

    The future (history) of socioeconomic measurement and implications for improving health outcomes among African Americans

    J Gerontol

    (2005)
  • R.S. Baker et al.

    Access to vision care in an urban low-income multiethnic population

    Ophthalmol Epidem

    (2005)
  • A. Bandura

    Social cognitive theory of mass communication

  • B. Bengtsson et al.

    A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension

    J Glaucoma

    (2005)
  • P.A. Braveman et al.

    Socioeconomic status in health research: one size does not fit all

    JAMA

    (2005)
  • G.W. Bylsma et al.

    Utilization of eye care services by Victorians likely to benefit from eye care

    Clin Exp Ophthalmol

    (2004)
  • P.A. Carney et al.

    Impact of telephone counseling intervention on transitions in stage of change and adherence to interval mammography screening (United States)

    Cancer Causes and Control

    (2005)
  • Y.P. Chiang et al.

    Office visits to ophthalmologists and other physicians for eye care among the U.S. population, 1990

    Pub Health Rep

    (1995)
  • N.G. Congdon et al.

    Important causes of visual impairment in the world today

    JAMA

    (2003)
  • A.G. Dawn et al.

    Patient expectations regarding eye care: focus group results

    Arch Ophthalmology

    (2003)
  • C. Delcourt et al.

    Risk factors for cortical, nuclear, and posterior subcapsular cataracts

    Am J Epidemiol

    (2000)
  • Department of Health & Human Services, Centers for Disease Control and Prevention: Improving the Nation’s Vision...
  • N.J. Ellish et al.

    Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans

    Inv Ophthalmology Vis Sci

    (2007)
  • K. Fiscella et al.

    Health disparities based on socioeconomic inequities: implications for urban health care

    Acad Med

    (2004)
  • P. Franks et al.

    Effects of patient and physician practice socioeconomic status on the health care of privately insured managed care patients

    Med Care

    (2003)
  • A.M. Fremont et al.

    Patterns of care for open-angle glaucoma in managed care

    Arch Ophthalmol

    (2003)
  • D.S. Friedman et al.

    An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma

    Am J Ophthalmol

    (2004)
  • A.H. Goodman

    Why genes don’t count (for racial difference in health)

    Am J Pub Health

    (2000)
  • J.L. Gottlieb

    Age-related macular degeneration

    JAMA

    (2002)
  • J.L. Haines et al.

    Complement factor H variant increases the risk of age-related macular degeneration

    Science

    (2005)
  • C.J. Hammond et al.

    Genes and environment in refractive error: the Twin Eye Study

    Invest Ophthalmol Vis Sci

    (2001)
  • M.I. Harris et al.

    Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study

    Diabetes Care

    (1998)
  • J.A. Harrison et al.

    A meta-analysis of studies of the Health Belief Model with adults

    Health Ed Research

    (1992)
  • Cited by (58)

    • Urgent unmet needs in the care of bacterial keratitis: An evidence-based synthesis

      2023, Ocular Surface
      Citation Excerpt :

      The need for further population-based interventions, however, is emphasized by recent evidence that suggests that visual impairment resulting from corneal infections remains heavily concentrated among the lowest socioeconomic classes, women, and the elderly [29,141,142]. While health disparities in the care of corneal infections have not been well-studied in higher income countries, it is not unreasonable to suggest that BK patients in MHICs are also affected by the patterns of unequal treatment access and delayed referrals that have been increasingly observed in ophthalmology [143–146]. Moreover, the preventable nature of most BK cases suggests that targeted health literacy campaigns – for instance those that promote meticulous contact lens hygiene [147,148] and safety glasses for injury-prone occupations [128,149,150] – have the potential to improve public health and reduce the overall burden of disease.

    • Improving Access to Eye Care: A Systematic Review of the Literature

      2022, Ophthalmology
      Citation Excerpt :

      In addition, another study identified psychological and behavioral characteristics that influence how retinal screening occurs in young adults with diabetes, suggesting that personalized resources and greater understanding among health care professionals of the social issues that affect the likelihood of participating in retinal screenings may be impactful for their vision care.48 As with other ocular health disorders, expanded insurance coverage for diabetes would mitigate barriers to quality eye care currently faced by patients with this disease.49–55 A review by Saydah et al56 stated that more than 8 million adults with refractive errors that could be corrected could not afford to purchase the glasses that would improve their vision.

    • Disparities in Vision Health and Eye Care

      2022, Ophthalmology
      Citation Excerpt :

      In addition to a diagnosis of type 1 or type 2 diabetes, there are several other diabetes-related risk factors for DR: higher hemoglobin A1c, insulin use, duration of disease, hypertension, and elevated blood glucose.176–178 Compared with White Americans, Black and Hispanic Americans tend to have a higher and more severe disease burden but lower rates of recommended screening and eye examinations.175,176,179,180 Moreover, despite advances in therapy, Black and Hispanic patients have more severe DR at the time treatment is initiated with anti-VEGF intravitreal injections.181

    View all citing articles on Scopus
    View full text